20-77-801. Definitions.

20-77-801. Definitions. As used in this subchapter: (1)(A) “Home intravenous drug therapy services” means the items and services described in subdivision (1)(B) of this section furnished to an individual who is under the care of a physician in a place of residence used as the individual's home, by a qualified home intravenous drug therapy provider, and under a plan established and periodically reviewed by a physician. (B) “Home intravenous drug therapy services” includes pharmacy and related services, including medical supplies, intravenous fluids, and equipment used in administering intravenous fluids as are necessary to conduct safely and effectively an intravenous-administered drug regimen; (2) “Qualified pharmacy home intravenous drug therapy provider” means any entity that the Arkansas State Board of Pharmacy determines meets the following requirements: (A) Is capable of providing home intravenous drug therapy services; (B) Makes services available, as needed, seven (7) days a week on a twenty-four-hour basis; (C) Adheres to the appropriate written protocols and policies with respect to the provision of items and services; (D) Maintains clinical records on all patients; (E) Coordinates all services with the patient's physician; (F) Maintains patient records as to frequency of nursing visits, certificate of medical necessity from the attending physician, progress reports on the patient, and a patient care plan; (G) Conducts a quality assessment and assurance program, including drug regimen review and coordination of patient care; (H) Provides sterile compounding of intravenous drugs in an atmosphere which contains less than one thousand (1,000) particles 0.5 microns or larger in diameter per cubic foot of air and positive air flow. Clean air hoods must be certified at least annually; (I) Performs stringent quality control procedures, including complete sterile compounding records of drug lot number, expiration date, quantity used, and a copy of the label attached to the final compounded product; (J) Is licensed by the board; and (K) Meets other requirements as the board may determine are necessary to assure the safe and effective provision of home intravenous drug therapy services and the efficient administration of home intravenous drug therapy; and (3) “Referring physician” means, with respect to providing home intravenous drug therapy services to an individual, a physician who: (A) Prescribed the home intravenous drug for which the services are to be provided; and (B) Established the plan of care for the services.